Watchlist Price Alert

Lumos Pharma Inc. (LUMO)

NASDAQ: LUMO · Real-Time Price · USD

4.34

0.00 (0.00%)

At close: Dec 11, 2024, 9:00 PM

Lumos Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-34.03M	-31.06M	-30.43M	-5.66M	-42.99M	-53.59M	-71.95M	-85.16M
Depreciation & Amortization	44K	49K	203K	584K	1.09M	1.15M	1.41M	2.08M
Stock-Based Compensation	2.32M	2.32M	2.88M	1.07M	6.72M	17.12M	18.51M	16.71M
Other Working Capital	679K	400K	-950K	-422K	2.62M	10.32M	19.1M	-27.91M
Other Non-Cash Items	-392K	-26K	14K	-5.87M	371K	102K	126K	-397K
Deferred Income Tax	n/a	n/a	n/a	-9.5M	n/a	n/a	n/a	3.96M
Change in Working Capital	965K	2.1M	-2.31M	-3.62M	4.59M	-2.71M	3.63M	-3.14M
Operating Cash Flow	-31.09M	-26.62M	-29.65M	-23M	-30.21M	-37.94M	-48.28M	-65.95M
Capital Expenditures	n/a	-21K	-30K	-30K	-2K	-7K	-43K	-2.25M
Cash Acquisitions	n/a	n/a	n/a	84.18M	n/a	124K	254K	n/a
Purchase of Investments	-7.38M	-11.34M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	18.12M	n/a	n/a	n/a	n/a	n/a	n/a	2.18M
Other Investing Acitivies	n/a	-11.34M	26M	32.5M	79K	124K	254K	-66K
Investing Cash Flow	10.74M	-11.36M	25.97M	116.65M	77K	117K	211K	-66K
Debt Repayment	n/a	n/a	n/a	-27K	n/a	-167K	-246K	-257K
Common Stock Repurchased	-1.31M	-675K	-114K	n/a	-36K	-275K	-289K	-82K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9K	-146K	-114K	102K	58K	n/a	1.41M	2.22M
Financial Cash Flow	-576K	-821K	-192K	75K	-59K	-148K	75.29M	1.88M
Net Cash Flow	-20.93M	-38.8M	-3.87M	93.73M	-30.19M	-37.97M	27.22M	-64.13M
Free Cash Flow	-31.09M	-26.64M	-29.68M	-23.03M	-30.21M	-37.95M	-48.32M	-68.19M